🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Opioids remain the first-line drugs for the treatment of moderate to severe...
Status
Completed
Location
Oslo University Hospital
Start Date
2017-12-04
Trial ID
NCT03314792
Treatments Being Tested
This is a Phase 2 study, involving a 4-week treatment period, designed to t...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-06
Trial ID
NCT01366014
The purpose of this study is to evaluate the safety and tolerability of Ega...
Status
Completed
Location
Site 334
Start Date
2016-03-07
Trial ID
NCT02603705
Treatments Being Tested
The purpose of this study is to estimate the effects of food and of sprinkl...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-10
Trial ID
NCT01456507
Treatments Being Tested
This study is to determine the feasibility of an n-of-1, randomized, double...
Status
Withdrawn
Location
University Health Network
Start Date
2019-05-01
Trial ID
NCT04132011
The purpose of the extension phase is to evaluate the long-term safety and ...
Status
Terminated
Location
Birmingham Pain Center
Start Date
2004-06
Trial ID
NCT01125917
The purpose of this study is to explore the clinical characteristics oral M...
Status
Terminated
Location
Lotus Clinical Research, LLC
Start Date
2014-11
Trial ID
NCT02381132
Treatments Being Tested
The study will evaluate the human abuse liability of PTI-821 (oxycodone ext...
Status
Completed
Location
PRA-EDS
Start Date
2017-05-15
Trial ID
NCT03475862
Treatments Being Tested
Objectives: 1. To evaluate the effect of liposomal bupivacaine on postoper...
Status
Terminated
Location
Loma Linda University Health System
Start Date
2015-07
Trial ID
NCT02659501
The primary objective is to demonstrate the safety and tolerability of COV7...
Status
Completed
Location
Genova Clinical Research
Start Date
2011-09-20
Trial ID
NCT01451385
Treatments Being Tested